Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strateg... (lansto launch its follow-on biologic ver...)

Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor

Date:7/17/2008

lans to launch its follow-on biologic versions of the innovator products when the patents on the innovator products expire.

"Chairman Thomas' legislative expertise and strategic counsel will prove invaluable in the coming months as Insmed continues in its mission to be the first US-based biotechnology company to develop a comprehensive portfolio of follow-on biologics products," said Dr. Geoffrey Allan, President and CEO of Insmed. "We want to demonstrate to Washington policymakers that the capability to produce safe, effective and more affordable biologics exists today. All that's needed is for Congress to create an approval pathway."

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com

The Follow-on Biologics Market

According to published reports, an estimated $10 billion worth of biologic drugs are expected to come off patent by 2010, with an additional $10 billion by 2015. FOBs would provide safe and effective therapies at a reduced cost following the expiration of the original product's patent. A recent econometric study by economist Dr. Robert J. Shapiro, former Under Secretary of Commerce in the Clinton Administration, found that "...generic versions of the top 12 categories of biologic treatments with patent protections that have expired or that are due to expire in the near future could save Americans $67 billion to $108 billion over 10 years and $236 billion to $378 billion over 20 years."

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to p
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Insmed Retains RBC Capital Markets as Strategic Financial Advisor
2. Insmed to Present at Collins Stewart Fourth Annual Growth Conference
3. Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination
4. Insmed Announces First Quarter 2008 Financial Results
5. Insmed to Present at CBI Follow-On Biologics Conference
6. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
7. Insmed Announces Additional Information in Compliance With NASDAQ Rules
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
10. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
11. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics

Post Your Comments:

(Date:12/16/2009)... has been found to be effectinve in improving yelds of probiotic ... ... BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for Non-Animal ... Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... has been found to be especially effective in improving yields of ...

(Date:12/15/2009)... of three Department of Energy (DOE) bio-energy research centers, ... its valuable intellectual property. , ... ... -- Surety, LLC , the leading provider of ... the Joint BioEnergy Institute (JBEI), one of three Department ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...

(Date:12/15/2009)... NeedleProbes™ for Atomic Force Microscopy (AFM) have been developed ... studies at the liquid/air interface. The NeedleProbes’ cylindrical geometry ... evaporation rate and viscosity - all in a single force ... ... 15, 2009 -- New, constant diameter NeedleProbes are ...

[0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM

... D facilities for Ap3ana, CTI,s ,personalized medicine, venture, ... (CTI),(Nasdaq: CTIC ) announced today that Christina ... of a Tyr Pharma and formerly Director of,Scientific ... has been named President of CTI Europe. Based ...

... (TSX; FSE: HBP) today announced that it has closed ... units at $1.68 per,unit, for gross proceeds totaling CDN$11,424,000., ... one-half of one common share,purchase warrant, with each whole ... to adjustment, one common share at a price,of $2.36 ...

... Business Update to Investors, WILMINGTON, Del., Oct. ... Vice President & General Manager John Ranieri,said the ... programs to,market are on track and making significant ... conversion of cellulosic feedstocks,economically into biofuels., "Biobutanol ...

Other Biology Technology:Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2 Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3 Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4 Helix Biopharma Closes $11.4 Million Private Placement 2 DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2 DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3

Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe Helix Biopharma Closes $11.4 Million Private Placement DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels

(Date:12/16/2009)... December 15, 2009 Signal Hill, CA Tom ... public and president of Bowman Global Change, has developed ... the fourth Intergovernmental Panel on Climate Change (IPCC) report ... to the authentic scientific information they need to make ... Bowman created the new format as a means to ...

(Date:12/16/2009)... PALM HARBOR, Fla., Dec. 2 ... CICI), a leading supplier of electronic signature ... financial industry* and the recognized leader** in ... ("Docubase"), a leading International Electronic Document Management ... have entered an agreement to provide their ...

(Date:12/16/2009)... CHURCH, Va., Dec. 9 CSC ... that the American Association for Laboratory Accreditation ... Commission (ISO/IEC) 17025:2005 accreditation to the company,s ... CSC Identity Labs located in Fairmont, W.Va. ... test laboratory in the world to achieve ...

Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4 CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2 Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 1 Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 2 Too Few Americans Get HIV Test Early Enough 50100 1 Too Few Americans Get HIV Test Early Enough 50100 2 Too Few Americans Get HIV Test Early Enough 50100 3 UnitedHealthcare and Fusion Sleep Announce New Agreement 50096 1 UnitedHealthcare and Fusion Sleep Announce New Agreement 50096 2

[0] Bowman creates graphic translation of climate change data [0] CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions [0] CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation

... mini-foods, especially if you,re a dieter. , Chronic ... packages are smaller, according to a new study in ... L. Scott, Stephen M. Nowlis, Naomi Mandel, and Andrea ... regarding "mini-packs," 100-calorie food packages that are marketed to ...

... release is available in German . , ... Allergy and the Center for Allergy and Environment of ... Mnchen have pinpointed a major gene for allergic diseases. ... examining the whole human genome at the Helmholtz Zentrum ...

... University and the University of St. Andrews, United Kingdom, have ... or may not easily cause a recollection of other associated, ... the way in which the learned information is forgotten. ... PLoS Computational Biology . , When one learns a language ...

Other Biology News:M&Ms as diet food? 100-calorie pack misconceptions 2 Munich researchers discover key allergy gene 2

M&Ms as diet food? 100-calorie pack misconceptions Munich researchers discover key allergy gene Relearning process not always a 'free lunch'

MAb to Myoglobin Cardiac...

... valuable tool for removing SDS detergent from ... in biological samples imparts a negative charge ... enzymatic activity during digestion, and suppresses ion ... mass spectrometry analyses. We recommend that ...

Cells are grown to a specified density and induced, when necessary. Protein expression samples are collected at 3 growth points and analyzed by SDS-PAGE/Coomassie....

NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....

Biology Products:

Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.SDSaway from Protea Biosciences, Inc.Bacterial Cell Paste Production Services from ARVYS Proteins, Inc.Cell biology services from Novascreen-a Caliper Life Sciences Company

Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strateg...(lansto launch its follow-on biologic ver...)